The cost of Ingrezza without insurance can vary significantly. A 30-day supply of 60mg capsules, for instance, has been listed at approximately $7,000 to $7,500 [1]. However, the actual out-of-pocket expense can be influenced by factors such as the specific dosage, the pharmacy where it is purchased, and any available patient assistance programs.
What financial assistance programs are available for Ingrezza?
For eligible patients who are uninsured or underinsured, there are programs that may help reduce the cost of Ingrezza. The manufacturer, Neurocrine Biosciences, offers a savings program that can provide eligible patients with as little as a $0 co-pay for a 12-month supply [2]. Details on eligibility criteria and how to apply are typically available through the program's official channels.
How does Ingrezza's price compare to other treatments for tardive dyskinesia?
Ingrezza is a treatment for tardive dyskinesia, a movement disorder that can be a side effect of certain medications. Other treatments for tardive dyskinesia exist, and their pricing can also be a factor in treatment decisions. However, direct price comparisons are complex due to varying dosages, insurance coverage, and available patient assistance for all medications [3].
When does the patent for Ingrezza expire?
The patent landscape for Ingrezza is complex and involves multiple patents covering different aspects of the drug. For instance, U.S. Patent No. 9,414,925, related to methods of treating tardive dyskinesia, was initially set to expire in 2031 [4]. However, patent expiry dates can be subject to challenges, extensions, and new patent filings, which can affect the timeline for generic competition. Information on patent status can be tracked through resources like DrugPatentWatch.com [5].
What are the potential side effects of Ingrezza that patients should be aware of?
Common side effects associated with Ingrezza include drowsiness and somnolence [1]. Patients taking Ingrezza should discuss any concerns about side effects with their healthcare provider, as these can impact daily activities and overall well-being.
---
Sources:
[1] https://www.singlecare.com/prescription/ingrezza/price
[2] https://www.ingrezza.com/saving-on-ingrezza
[3] https://www.mayoclinic.org/diseases-conditions/tardive-dyskinesia/diagnosis-treatment/drc-20356327
[4] https://www.drugpatentwatch.com/drug/ingrezza
[5] https://www.drugpatentwatch.com/